[Lab] split one vial across PeptideMeter and VendorInvestigate — 98.4% and 97.2%
Posting this because the title is the whole finding — split one vial across PeptideMeter and VendorInvestigate — 98.4% and 97.2% — and a number without its method is a rumour. 98.4% and 97.2%. Those are measured, not estimated, and not rounded up in my favour. The distribution matters more than the mean. In the trial…
Research-use-only material is not approved for human use. Anything in this thread about how a research vial "should" titrate is a discussion about chemistry, not a plan.
Are you comparing yourself with the trial mean or with the people who post the most?
Week 74 was the first time the scale moved after a five-week stall. I changed nothing in that window.
week 3 is early to draw any conclusion at all
Came off sema and onto tirz with a two-week gap. The first month was flat and I assumed I had made a mistake. Month two it moved.
SURMOUNT-1 ran 72 weeks with the top arm around 21% mean body weight change. SURPASS is the diabetes programme and reports glycaemic endpoints, so quoting the two interchangeably is a category error.
Yes. I stepped to 12.5 because the calendar said so, not because anything needed fixing, and I regretted it for a fortnight.
SURMOUNT-1 landed around 21% at 72 weeks on the top arm
The 21% figure is a 72-week mean on the highest arm. Quoting it as what someone should expect by week 86 is not a fair reading.
Not sure that follows. You went up a step and changed your training in the same fortnight.
hold the dose that works, the ladder is not a leaderboard